Nervgen Pharma NGEN
NASDAQ NGEN
$1.93 +0.01 (+0.52%)
As of: Sep 30, 2026 · 1:16 PM EDT

Nervgen Pharma Corp. (NGEN) Operating Expenses (2025 - 2026)

Updated

Nervgen Pharma (NGEN) recorded Operating Expenses of $8.82 million in the quarter ended Jun 30, 2026, up 88.9% from $4.67 million a year earlier and up 60.5% from the prior quarter.

Analysis

Nervgen Pharma Corp. (NGEN) Operating Expenses (2025 - 2026) Analysis & Trends

On a TTM basis, Nervgen Pharma's Operating Expenses came in at $23.18 million as of Jun 30, 2026; for the year ended Dec 31, 2025, it was $17.95 million, down 2.4% from the prior year.

  • Across earlier years, Operating Expenses came in at $18.39 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.82 Mn
Mar 31, 2026 5.49 Mn
Jun 30, 2025 4.67 Mn
Mar 31, 2025 4.21 Mn
API Access

Nervgen Pharma Corp. Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=NGEN&period=max&api_key=YOUR_API_KEY